U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
139594
Name Type Language
Raxorulimogene belzovacirepvec transgene (IgGL–T2A-αCTLA4-IgGH)
Common Name English
Raxorulimogene belzovacirepvec transgene (anti-cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) immunoglobulin G1 γ1-chain fused via a synthetic T2A peptide with human immunoglobulin kappa chain (anti-CTL4 antibody) with the Igκ signal sequence for
Common Name English
Code System Code Type Description
FDA UNII
63SFS9Q5ZB
Created by admin on Sat Dec 16 19:16:49 UTC 2023 , Edited by admin on Sat Dec 16 19:16:49 UTC 2023
PRIMARY
Sugar Site Range Site Count
Deoxyribose (DNA) 1_1-1_2184 2184 / 2184
Linkage Site Range Site Count
Phosphate 1_2-1_2184 2183 / 2183
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966